All

× UPDATE! Updated as of 24 May 2024.
Records 221 to 240 of 32645
 
Product Information
Registration Number
Generic Name
Brand Name
Dosage Strength
Dosage Form
Classification
Pharmacologic Category
Manufacturer
Country of Origin
Application Type
Issuance Date
Expiry Date
View BR-1380 Human Immunoglobulin Pentaglobin 50 mg/ mL Solution for Infusion (IV) Prescription Drug (RX) - Biotest AG Germany - 16 November 2021 16 November 2026
View BR-1381 Calfactant Infasurf 35 mg/mL Intratracheal Suspension Prescription Drug (RX) - ONY Biotech Inc. United States of America Initial (correction) 29 July 2022 23 November 2026
View BR-1382_PI_01.PDF BR-1382 Moroctocog Alfa Xyntha 250 IU Lyophilized Powder for Injection (IV) Prescription Drug (RX) - Wyeth Farma, S.A. Spain - 10 December 2021 10 December 2026
View BR-1383_PI_01.PDF BR-1383 Moroctocog Alfa Xyntha 500 IU Lyophilized Powder for Injection (IV) Prescription Drug (RX) - Wyeth Farma, S.A. Spain - 10 December 2021 10 December 2026
View BR-1384 Cholera Vaccine (Inactivated, Oral) Euvichol-Plus Formulation Each dose (1.5 mL), contains Vibrio cholerae 01 Inaba Cairo 48 classical biotype, Heat inactivated Vibrio cholerae 01 Inaba Phil 6973 El Tor biotype, Formalin inactivated Vibrio cholerae 01 Ogawa Cairo 50 classical biotype, Formalin inactivated Vibrio cholerae 01 Ogawa Cairo 50 classical biotype, Heat inactivated Vibrio cholerae 0139 4260B, Formalin inactivated 300 LEU* 600 LEU* 300 LEU* 300 LEU* 600 LEU* *LEU: Lipopolysaccharide ELISA Units Oral Suspension Prescription Drug (RX) - Eubiologici Co., Ltd Korea - 31 December 2021 31 December 2026
View BR-1385 Bevacizumab Avamab 400 mg/16 mL (25 mg/mL) Concentrate for Solution for Infusion (IV) Prescription Drug (Rx) - Sinergium Biotech S.A. Argentine Republic - 02 February 2022 02 February 2027
View BR-1386 Bevacizumab Avamab 100 mg/4 mL (25 mg/mL) Concentrate for Solution for Infusion (IV) Prescription Drug (Rx) - Sinergium Biotech S.A. Argentine Republic - 02 February 2022 02 February 2027
View BR-1389_PI_01.pdf BR-1389 Insulin Degludec Tresiba Flextouch 100 Units/mL Solution for Injection (SC) Prescription Drug (RX) - Novo Nordisk Production SAS France Initial (Variation) 23 November 2023 23 November 2028
View BR-1390_PI_01 NO RX SYMBOL.pdf BR-1390 Romosozumab Evenity 105 mg/ 1.17 mL Solution for Injection (SC) Prescription Drug (Rx) - Patheon Italia S.p.A Italy Monitored Release (MR) 29 March 2022 29 March 2025
View BR-1388 Meningococcal Group A, C, W-135 and Y Conjugate Vaccine Menquadfi Formulation: Each dose (0.5 mL) contains: Neisseria meningitidis group A polysaccharide* .... 10 mcg Neisseria meningitidis group C polysaccharide* .... 10 mcg Neisseria meningitidis group Y polysaccharide* .... 10 mcg Neisseria meningitidis group W-135 polysaccharide* .... 10 mcg *Conjugated to Tetanus Toxoid carrier protein... 55 mcg** **Tetanus Toxoid quantity is approximate and dependent on the polysaccharide to protein ratio for the conjugates in each formulation Solution for Injection (IM) Prescription Drug (RX) - Sanofi Pasteur United States of America Monitored Release 04 March 2022 04 March 2027
View BR-1391 Heparin Sodium Avirin 1,000 IU/mL Solution for Injection (IV/SC) Prescription Drug (RX) - 2 World Laboratories India - 30 March 2022 11 August 2026
View BR-1392 Rabies Vaccine (Inactivated) Bioshoot 2.5 IU Powder for Solution for Injection (IM) Prescription Drug (RX) - Changchun Zhuoyi Biological Co., Ltd. China Initial 30 March 2022 30 March 2027
View BR-1393 Human Fibrinogen + Human Thrombin TachoSil 5.5 mg/2.0 IU per cm2 Medicated Sponge Prescription Drug (Rx) Local Hemostatic Agents TAKEDA AUSTRIA GMBH Austria Renewal 07 April 2024 04 March 2029
View BR-1394 Trastuzumab Trazimera 150 mg Powder For Concentrate For Solution For Infusion (Iv) Prescription Drug (RX) - Pfizer Manufacturing Belgium NV Belgium Initial (Variation) 08 August 2023 08 August 2028
View BR-1395 Trastuzumab Trazimera 440 mg Powder For Concentrate For Solution For Infusion (Iv) Prescription Drug (RX) - Pfizer Manufacturing Belgium NV Belgium Initial (Variation) 08 August 2023 08 August 2028
View BR-1396 Polatuzumab vedotin Polivy 140 mg Powder for Concentrate for Solution for Infusion (IV) Prescription Drug (Rx) - BSP Pharmaceuticals S.p.A. Italy Monitored Release 01 April 2022 01 April 2027
View BR-1397_PI_01.pdf BR-1397 Brolucizumab Vsiqq 120 mg/mL (27.6 mg/0.23 mL) Solution For Injection (Intravitreal) Prescription Drug (RX) - Novartis Pharma Stein AG Technical Operations Schweiz, Stein Steriles Switzerland Monitored Release (Variation) 27 February 2023 27 February 2028
View BR-1398_PI_01.pdf BR-1398 Secukinumab Cosentyx 300 mg/ 2 mL Solution For Injection (SC) Prescription Drug (RX) - Novartis Pharma Stein AG, Pharmaceutical Operations Schweiz Steriles Switzerland - 13 April 2022 13 April 2027
View BR-1399 Secukinumab Cosentyx 300 mg/ 2 mL Solution For Injection (SC) Prescription Drug (RX) - Novartis Pharma Stein AG, Pharmaceutical Operations Schweiz Steriles Switzerland - 13 April 2022 13 April 2027
View BR-1400 Trastuzumab Trazimera 440 mg Powder for Concentrate for Solution for Infusion (IV) Prescription Drug (RX) - Pfizer Manufacturing Belgium NV Belgium - 21 April 2022 21 April 2027